- For many people, mild cognitive impairment can be the first sign of Alzheimer’s disease.
- Researchers from AgeneBio and Johns Hopkins University are examining the use of a once-a-day investigational medication to treat amnestic mild cognitive impairment due to Alzheimer’s disease.
- Scientists found the drug helped slow brain atrophy progression in people with mild cognitive impairment due to Alzheimer’s disease who are not carriers of the APoE-4 genetic variant.
“Our studies have shown…
Read the full article here